China Unveils 2025 Medical Device Inspection Strategy to Tighten Quality Control
Medical DevicePolicy / Regulatory

China Unveils 2025 Medical Device Inspection Strategy to Tighten Quality Control

Eisai Transfers Pariet Rights in China to CBC Group-Controlled Peak Pharma
CompanyDeals

Eisai Transfers Pariet Rights in China to CBC Group-Controlled Peak Pharma

Sinovac Biotech's SNA02-48 Granted Clinical Approval for Tetanus Prevention
CompanyDrug

Sinovac Biotech’s SNA02-48 Gains Clinical Approval for Tetanus Prevention

Shanghai Designates Backup Suppliers and Specialized Drug Formulations in GY-YD2024-2 Procurement
Policy / Regulatory

Shanghai Designates Backup Suppliers and Specialized Drug Formulations in GY-YD2024-2 Procurement

Abbott Laboratories' Volt PFA System Receives EU CE Mark for Atrial Fibrillation Treatment
CompanyMedical Device

Abbott Laboratories’ Volt PFA System Receives EU CE Mark for Atrial Fibrillation Treatment

Alcon Laboratories Acquires Majority Stake in Aurion Biotech to Advance Eye Disease Cell Therapy
CompanyDeals

Alcon Laboratories Acquires Majority Stake in Aurion Biotech to Advance Eye Disease Cell Therapy

Genmab's Tivdak Approved in Japan for Advanced Cervical Cancer Treatment
CompanyDrug

Genmab’s Tivdak Approved in Japan for Advanced Cervical Cancer Treatment

CStone Pharmaceuticals Reports 2024 Results with License Fee Growth Offsetting Drug Sales Decline
Company

CStone Pharmaceuticals Reports 2024 Results with License Fee Growth Offsetting Drug Sales Decline

TransThera and Akeso Biopharma Collaborate on HCC Study with Tinengotinib and Bispecific Antibodies
CompanyDeals

TransThera and Akeso Biopharma Collaborate on HCC Study with Tinengotinib and Bispecific Antibodies

NMPA Approves Qingfeng's Suraxavir Marboxil for Influenza A and B Treatment
CompanyDrug

NMPA Approves Qingfeng’s Suraxavir Marboxil for Influenza A and B Treatment

Medtronic Launches Digital Innovation Base in Beijing's BioPark
Company

Medtronic Launches Digital Innovation Base in Beijing’s BioPark

Huadong Medicine Gains NMPA Approval for HDM3019 Rheumatoid Arthritis Trial
CompanyDrug

Huadong Medicine Gains NMPA Approval for HDM3019 Rheumatoid Arthritis Trial